Bone Marrow NeoplasmsBone Marrow DiseasesBone MarrowBone Marrow TransplantationTransplantation, AutologousBone Marrow CellsNeuroblastomaBone Marrow PurgingBone and BonesCombined Modality TherapyCyclophosphamideCarmustineWhole-Body IrradiationLymphoma, Non-HodgkinHematopoietic Stem CellsMelphalanAntineoplastic Combined Chemotherapy ProtocolsColony-Forming Units AssayBone Marrow ExaminationEtoposideHodgkin DiseaseHematopoietic Stem Cell TransplantationHematopoiesisRemission InductionTransplantation, HomologousLeukemia, Myeloid, AcuteBone RemodelingCytarabineBusulfanTreatment OutcomeBone TransplantationThiotepaDrug EvaluationLeukemiaLeukemia, MyeloidRecurrenceVincristineTransplantation ConditioningTime FactorsPodophyllotoxinBone DensityMultiple MyelomaPrecursor Cell Lymphoblastic Leukemia-LymphomaStem Cell TransplantationLymphomaActuarial AnalysisCell DifferentiationGranulocytesSalvage TherapySurvival AnalysisAntigens, CD34Granulocyte Colony-Stimulating FactorGraft vs Host DiseaseCells, CulturedBone ResorptionGranulocyte-Macrophage Colony-Stimulating FactorCell SeparationStromal CellsLeukocyte CountBlood Cell CountMice, Inbred C57BLGraft SurvivalFollow-Up StudiesHematologic DiseasesFlow CytometryBone NeoplasmsAntibodies, MonoclonalDisease-Free SurvivalSurvival RatePlatelet CountMyelodysplastic SyndromesBlood Transfusion, AutologousMesenchymal Stem Cell TransplantationDoxorubicinBone RegenerationMesnaMitoxantroneAcute DiseaseHematopoietic Stem Cell MobilizationThrombocytopeniaT-LymphocytesLymphatic IrradiationPrognosisAnemia, AplasticAgranulocytosisBone SubstitutesNeutropeniaRadiation ChimeraOsteogenesisPrednisoneLomustineRecombinant ProteinsBone DevelopmentStem CellsAutograftsLymphoma, FollicularImmunophenotypingAntigens, CDBone DiseasesProspective Studies